Back
Protalix BioTherapeutics Stock Price Chart
Sponsored
PLX
Sponsored
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
PLX
Protalix BioTherapeutics
Last Price:
1.08
Seasonality Move:
79.27%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Protalix BioTherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.04 | Buy |
20-day SMA: | 0.99 | Buy |
50-day SMA: | 1.04 | Buy |
200-day SMA: | 1.29 | Sell |
8-day EMA: | 1.04 | Buy |
20-day EMA: | 1.02 | Buy |
50-day EMA: | 1.04 | Buy |
200-day EMA: | 1.25 | Sell |
Protalix BioTherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 60.41 | Buy |
Chaikin Money Flow: | 82656 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.94 - 1.04) | Buy |
Bollinger Bands (100): | (1.01 - 1.19) | Sell |
Protalix BioTherapeutics Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.09 while PLX 8-day simple moving average is 1.04, which is a Buy signal.
- The stock price of PLX is 1.09 while Protalix BioTherapeutics 20-day SMA is 0.99, which makes it a Buy.
- Protalix BioTherapeutics 50-day simple moving average is 1.04 while PLX share price is 1.09, making it a Buy technically.
- PLX stock price is 1.09 and Protalix BioTherapeutics 200-day simple moving average is 1.29, creating a Sell signal.
PLX Technical Analysis vs Fundamental Analysis
Buy
57
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a Buy
The current Protalix BioTherapeutics [PLX] share price is $1.09. The Score for PLX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
80.16M
Price in USD:
1.09
Share Volume:
82.66K
Protalix BioTherapeutics 52-Week Range
52-Week High:
1.90
52-Week Low:
0.82
Buy
57
Protalix BioTherapeutics (PLX)
is a Buy
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?
The Protalix BioTherapeutics stock price is 1.09 USD today. -
Will PLX stock go up or go down?
Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protalix BioTherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is not overvalued.
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.09 while PLX 8-day exponential moving average is 1.04, which is a Buy signal.
- The stock price of PLX is 1.09 while Protalix BioTherapeutics 20-day EMA is 1.02, which makes it a Buy.
- Protalix BioTherapeutics 50-day exponential moving average is 1.04 while PLX share price is 1.09, making it a Buy technically.
- PLX stock price is 1.09 and Protalix BioTherapeutics 200-day simple moving average is 1.25, creating a Sell signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
- PLX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Protalix BioTherapeutics is a Buy
- Protalix BioTherapeutics Relative Strength Index (RSI) is 60.41, which suggest Protalix BioTherapeutics is overbought
- The Bollinger Bands (25) for Protalix BioTherapeutics is (0.94 - 1.04), which suggest Protalix BioTherapeutics is a Sell
- The Bollinger Bands (100) for Protalix BioTherapeutics is (1.01 - 1.19), which suggest Protalix BioTherapeutics is a Sell
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.